Pulmonx Corporation
LUNG
$1.35
-$0.05-3.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 25.31% | 8.01% | -5.02% | -9.66% | 6.85% |
| Total Depreciation and Amortization | -6.10% | -17.73% | 7.55% | -5.44% | -21.81% |
| Total Amortization of Deferred Charges | 7.14% | 7.69% | 18.18% | 0.00% | 0.00% |
| Total Other Non-Cash Items | -15.66% | -9.91% | 9.90% | 6.90% | -5.96% |
| Change in Net Operating Assets | -1,213.28% | -102.74% | 197.57% | -706.21% | -4.36% |
| Cash from Operations | 13.21% | -108.85% | 70.44% | -96.46% | 7.07% |
| Capital Expenditure | 85.39% | -81.63% | 83.72% | -171.17% | 73.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 59.42% | -66.78% | 17.18% | 97.82% |
| Cash from Investing | -100.15% | 59.22% | -66.46% | 15.97% | 108.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5,000.00% | 97.92% | -- | -- | -- |
| Issuance of Common Stock | -48.29% | 632.14% | -95.78% | 498.20% | -75.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 51.06% | -- | -- | -- |
| Cash from Financing | -69.61% | 370.15% | -110.09% | 970.97% | -86.49% |
| Foreign Exchange rate Adjustments | -32.11% | 160.89% | -455.24% | -154.40% | 262.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -726.82% | 18.84% | -74.99% | -51.92% | 5,127.81% |